Skip to main content Accessibility help
×
×
Home

Cyproheptadine Treatment in Neuroleptic-Induced Akathisia

  • David Weiss (a1), Dov Aizenberg (a1), Haggai Hermesh (a1), Zvi Zemishlany (a1), Hanan Munitz (a1), Margaret Radwan (a1) and Abraham Weizman (a2)...
Abstract
Background

Cyproheptadine, an antiserotonergic agent, was used to treat neuroleptic-induced akathisia.

Method

In an open clinical trial 17 neuroleptic-treated patients with akathisia were administered cyproheptadine (16 mg/day) over 4 days. Assessment of akathisia, psychosis and depression were monitored by BAS, BPRS and HAM-D.

Results

All subjects showed improvement in the severity of akathisia, which in the majority (15/17) was of a marked degree. There was no aggravation of psychosis or depression. Symptoms of akathisia returned when cyproheptadine was discontinued.

Conclusions

Cyproheptadine may be useful in neuroleptic-induced akathisia.

Copyright
Corresponding author
Dr Dov Aizenberg, Gehah Psychiatric Hospital, Beilinson Medical Center, PO Box 102, Petah Tiqva 49 100, Israel
References
Hide All
Barnes, T. R. E. (1989) A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154, 672676.
Barnes, T. R. E., Halstead, S. M. & Little, P. W. A. (1992) Relationship between iron status and chronic akathisia in an in-patient population with chronic schizophrenia. British Journal of Psychiatry, 161, 791796.
Garrison, J. C. (1990) Histamine, bradykinin, 5-HT and their antagonists. In Goodman and Gilman's The Pharmacological Basis of Therapeutics (eds Gilman, A. G., Rall, T. W., Nies, A. S., et al), pp. 575599. New York: Pergamon Press.
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology (rev. edn). Washington, DC: US Department of Health, Education and Welfare.
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 5662.
Lipinski, J. F. Jr, Mallya, G., Zimmerman, P., et al (1989) Fluoxetine induced akathisia: clinical and theoretical implications. Journal of Clinical Psychiatry, 50, 339342.
Marsden, C. D. & Jenner, P. (1980) The pathophysiology of extrapyramidal side effects of neuroleptic drugs. Psychological Medicine, 10, 5572.
Miller, C. H., Fleishacker, W. W., Ehrmann, H., et al (1990) Treatment of neuroleptic-induced akathisia with the 5HT2 antagonist ritanserin. Psychopharmacology Bulletin, 26, 373376.
Overall, J. E. & Gorham, D. R. (1962) The brief psychiatric rating scale. Psychology Report, 10, 799812.
Power, A. C. & Cowen, P. J. (1992) Fluoxetine and suicidal behavior: some clinical and theoretical aspects of a controversy. British Journal of Psychiatry, 161, 735741.
Sadchev, P. & Loneragan, M. A. (1991) The present status of akathisia. Journal of Nervous and Mental Diseases, 179, 381391.
Silver, H., Blackler, M., Weller, M. P. I., et al (1991) The treatment of chronic schizophrenia with cyproheptadine: A double blind placebo-controlled study. Biological Psychiatry, 30, 523535.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Cyproheptadine Treatment in Neuroleptic-Induced Akathisia

  • David Weiss (a1), Dov Aizenberg (a1), Haggai Hermesh (a1), Zvi Zemishlany (a1), Hanan Munitz (a1), Margaret Radwan (a1) and Abraham Weizman (a2)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *